➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Johnson and Johnson
Medtronic
Colorcon
McKinsey

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Claims for Patent: 9,561,208


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,561,208
Title:Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
Abstract: An aqueous formulation for topical application to the skin comprising water, a water-miscible organic solvent, and benzoyl peroxide, wherein the concentration of the organic solvent is sufficient to provide a stable suspension of benzoyl peroxide in the aqueous formulation without the inclusion of a surfactant in the formulation, wherein the ratio of concentrations of water and organic solvent in the formulation is sufficient to maintain the benzoyl peroxide in saturated solubility in the formulation following application to the skin, and wherein the concentration of benzoyl peroxide in the formulation is less than 5.0% and at least 1.0% w/w. The formulation may further contain a chemical compound in addition to benzoyl peroxide that is effective in the treatment of acne. The aqueous formulations of the invention are useful in the treatment of acne and acne rosacea.
Inventor(s): Chang; Yunik (Clermont, FL), Dow; Gordon J. (Santa Rosa, CA)
Assignee: Dow Pharmaceutical Sciences, Inc. (Petaluma, CA)
Application Number:15/094,895
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,561,208
Patent Claims: 1. An aqueous suspension formulation for topical application to the skin, comprising 2.5% w/w to 4.5% w/w benzoyl peroxide, about 1.2% w/w clindamycin phosphate, propylene glycol, a carboxyvinyl polymer, and water; wherein the combined concentration of water and propylene glycol is sufficient to provide a suspension of benzoyl peroxide in a saturated solution of benzoyl peroxide, wherein the ratio of water to propylene glycol in the formulation ranges from 12:1 to 20:1, and wherein the concentration of the propylene glycol is one to four times the concentration of the benzoyl peroxide.

2. The formulation of claim 1, wherein the concentration of benzoyl peroxide ranges from 2.5% to 3.5% w/w.

3. The formulation of claim 1, wherein the concentration of benzoyl peroxide is about 3.5% w/w.

4. The formulation of claim 1, wherein the concentration of propylene glycol is about 5.0% w/w, the concentration of the carboxyvinyl polymer is about 1.75% w/w, and the ratio of water to propylene glycol in the formulation ranges from 12:1 to 18:1.

5. The formulation of claim 1, which is free of surfactant.

6. The formulation of claim 1, which contains a surfactant.

7. The formulation of claim 1, wherein the concentration of propylene glycol is about 5.0% w/w, the concentration of the carboxyvinyl polymer is about 1.75% w/w, and the ratio of water to propylene glycol in the formulation is about 18:1.

8. The formulation of claim 4, which is free of surfactant.

9. The formulation of claim 4, which contains a surfactant.

10. A method for treating acne, comprising applying to the skin of a patient in need thereof an aqueous suspension formulation comprising 2.5% w/w to 4.5% w/w benzoyl peroxide, about 1.2% w/w clindamycin phosphate, propylene glycol, a carboxyvinyl polymer, and water; wherein the combined concentration of water and propylene glycol is sufficient to provide a suspension of benzoyl peroxide in a saturated solution of benzoyl peroxide, wherein the ratio of water to propylene glycol in the formulation ranges from 12:1 to 20:1, wherein the concentration of the propylene glycol is one to four times the concentration of the benzoyl peroxide, and wherein the formulation is applied once a day for up to 12 weeks to the skin of the patient.

11. The method of claim 10, wherein the concentration of benzoyl peroxide in the formulation ranges from 2.5% to 3.5% w/w.

12. The method of claim 10, wherein the concentration of benzoyl peroxide in the formulation is about 3.5% w/w.

13. The method of claim 10, wherein the concentration of propylene glycol in the formulation is about 5.0% w/w, the concentration of the carboxyvinyl polymer in the formulation is about 1.75% w/w, and the ratio of water to propylene glycol in the formulation ranges from 12:1 to 18:1.

14. The method of claim 10, wherein the formulation is free of surfactant.

15. The method of claim 10, wherein the formulation contains a surfactant.

16. The method of claim 10, wherein the concentration of propylene glycol is about 5.0% w/w, the concentration of the carboxyvinyl polymer is about 1.75% w/w, and the ratio of water to propylene glycol in the formulation is about 18:1.

17. The method of claim 13, wherein the formulation is free of surfactant.

18. The method of claim 13, wherein the formulation contains a surfactant.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
McKesson
Johnson and Johnson
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.